D'ELIOS, MARIO MILCO
 Distribuzione geografica
Continente #
NA - Nord America 14.467
EU - Europa 12.082
AS - Asia 5.568
SA - Sud America 845
AF - Africa 169
OC - Oceania 132
Continente sconosciuto - Info sul continente non disponibili 3
Totale 33.266
Nazione #
US - Stati Uniti d'America 14.352
PL - Polonia 4.619
RU - Federazione Russa 3.417
SG - Singapore 1.528
HK - Hong Kong 1.368
CN - Cina 1.180
IE - Irlanda 910
IT - Italia 875
SE - Svezia 731
BR - Brasile 702
KR - Corea 622
DE - Germania 366
UA - Ucraina 355
FI - Finlandia 344
VN - Vietnam 290
IN - India 189
GB - Regno Unito 165
AU - Australia 130
FR - Francia 126
ID - Indonesia 84
TR - Turchia 67
CI - Costa d'Avorio 62
JO - Giordania 53
CA - Canada 49
CH - Svizzera 49
JP - Giappone 46
AR - Argentina 42
MX - Messico 40
NL - Olanda 35
ZA - Sudafrica 31
IQ - Iraq 29
BD - Bangladesh 27
EC - Ecuador 27
ES - Italia 22
VE - Venezuela 18
AT - Austria 17
BE - Belgio 16
SC - Seychelles 14
MA - Marocco 13
CO - Colombia 12
PE - Perù 11
PK - Pakistan 11
BJ - Benin 10
DZ - Algeria 10
PY - Paraguay 10
BO - Bolivia 9
KE - Kenya 9
UZ - Uzbekistan 9
CL - Cile 8
LT - Lituania 7
SA - Arabia Saudita 7
DO - Repubblica Dominicana 6
IR - Iran 6
JM - Giamaica 6
KG - Kirghizistan 6
TN - Tunisia 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
DK - Danimarca 5
EG - Egitto 5
KZ - Kazakistan 5
BH - Bahrain 4
CZ - Repubblica Ceca 4
NP - Nepal 4
GE - Georgia 3
HN - Honduras 3
IL - Israele 3
LB - Libano 3
MY - Malesia 3
PH - Filippine 3
SN - Senegal 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CR - Costa Rica 2
EU - Europa 2
HR - Croazia 2
LV - Lettonia 2
MM - Myanmar 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BW - Botswana 1
CG - Congo 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
HU - Ungheria 1
MD - Moldavia 1
MK - Macedonia 1
Totale 33.259
Città #
Warsaw 4.616
Santa Clara 3.018
Fairfield 1.416
Ashburn 1.192
Singapore 1.008
Hong Kong 972
Dublin 905
Chandler 833
Woodbridge 643
Seoul 619
Cambridge 611
Seattle 584
Jacksonville 538
Houston 516
Wilmington 475
Beijing 358
Hefei 306
Ann Arbor 264
San Jose 249
Princeton 237
Altamura 226
Lawrence 211
Buffalo 202
Los Angeles 183
Florence 156
Boardman 152
Boston 137
Medford 136
Mumbai 133
Melbourne 127
Dallas 123
Moscow 122
Munich 100
Helsinki 92
Ho Chi Minh City 87
New York 85
San Diego 79
Paris 77
Dong Ket 76
São Paulo 74
The Dalles 73
Jakarta 68
Abidjan 62
Shanghai 57
Kent 56
Turku 50
Tokyo 44
Council Bluffs 43
Hanoi 40
Redondo Beach 40
Norwalk 37
Phoenix 37
Bern 36
Izmir 36
London 31
Clifton 30
Milan 30
Falls Church 29
Verona 28
Hillsboro 26
Toronto 25
Rio de Janeiro 24
Denver 22
Chicago 21
West Jordan 21
Yubileyny 21
Salerno 20
Auburn Hills 19
Andover 17
Belo Horizonte 17
Brooklyn 17
Frankfurt am Main 17
Bengaluru 15
Dearborn 15
Johannesburg 15
Brussels 14
Goiânia 14
Guayaquil 14
Orem 14
Barcelona 13
Frankfurt Am Main 13
Lappeenranta 13
Redwood City 13
Vienna 13
Curitiba 12
Guangzhou 12
Haiphong 12
Montreal 12
Tianjin 12
Chennai 11
Mexico City 11
North Bergen 11
San Francisco 11
Baghdad 10
Brasília 10
Cotonou 10
Poplar 10
Guarulhos 9
Siena 9
Tashkent 9
Totale 23.369
Nome #
Behçet's syndrome patients exhibit specific microbiome signature. 434
H(+),K(+)-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 381
H+K+-A Tpase (proton pump) is the target autoantigen of Thl-type cytotoxic T cells in autoimmune gastritis 365
H(+),K(+)-atpase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. 359
Human 60 kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. 336
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. 336
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma. 317
Treponema pallidum (syphilis) antigen TpF1 induces angiogenesis through the activation of the IL-8 pathway 317
The Helicobacter cinaedi antigen CAIP participates in atherosclerotic inflammation by promoting the differentiation of macrophages in foam cells 315
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 314
Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. 306
Arterial occlusion mimicking vasculitis in a patient with incontinentia pigmenti 301
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. 297
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 294
Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells 292
Myelin-specific T cells carry and release magnetite PGLA-PEG COOH nanoparticles in the mouse central nervous system 287
Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. 282
A T cell suppressive circuitry mediated by CD39 and regulated by ShcC/RAI is induced in astrocytes by encephalitogenic T cells 273
Marcatori e funzioni dei linfociti th1 e th2. 273
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 270
The Neutrophil Activating Protein of Helicobacter pylori promotes T helper type 1 immune responses. 266
CD25 deficiency: A new conformational mutation prevents the receptor expression on cell surface 266
The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling. 265
Reply to letter by Nardelli and Schell commenting on the pathogenesis of Lyme arthritis 264
Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts 260
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. 250
Structure and immunomodulatory property relationship in NapA of Borrelia burgdorferi. 248
Molecular mimicry between Helicobacter pylori antigens and H/K-ATPase in human gastric autoimmunity. 248
p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes 248
Cytokine BAFF released by Helicobacter pylori-infected macrophages triggers the Th17 response in human chronic gastritis. 246
T cells in gastric cancer: friends or foes. 245
Digital ulcers secondary to Sneddon's syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis 241
Th1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease 240
Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis 237
USE OF THE NEUTROPHIL ACTIVATING PROTEIN OF HELICOBACTER PYLORI (HP-NAP) AND/OR OF ITS PORTIONS AS ADJUVANTS FOR THE DEVELOPMENT OF T HELPER TYPE 1 (TH1) IMMUNE RESPONSES 236
T helper type-1 lymphocyte-drive inflammation in human atherosclerotic lesions. 234
A Robust Design for Cellular Vehicles of Gold Nanorods for Multimodal Imaging 234
T cell clones in human trichinellosis: evidence for a mixed Th1/Th2 response 231
LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy 228
The immune modulating activity of the Helicobacter pylori HP-NAP: friend or foe? 226
Bioethics under the Tuscan sun 222
T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. 209
Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis 208
Cytotoxic T Cells in H. pylori -Related Gastric Autoimmunity andGastric Lymphoma 201
The lipoprotein HP1454 of Helicobacter pylori regulates T-cell response by shaping T-cell receptor signalling 200
Thrombosis in vasculitis: from pathogenesis to treatment 194
Intrinsic factor recognition promotes T helper 17/T helper 1 autoimmune gastric inflammation in patients with pernicious anemia. 181
Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets 176
Inflammatory marker changes in a 24-month dietary and physical activity randomised intervention trial in postmenopausal women 175
Characterization of H/K-ATPase T-cell epitopes in human autoimmune gastritis. 173
In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. 172
The immune receptor CD300e negatively regulates T cell activation by impairing the STAT1-dependent antigen presentation 172
The glycopeptide csf114(glc) detects serum antibodies in multiple sclerosis. 172
Role of Mycobacterium avium lysate INF-γ, IL-17, and IL-2 ELISPOT assays in diagnosing nontuberculous mycobacteria lymphadenitis in children 170
Role of Th1/Th2 cytokines in HIV infection. 169
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome 168
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. 166
The adaptor protein Rai/ShcC promotes astrocyte-dependent inflammation during Experimental Autoimmune Encephalomyelitis. 166
Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function 166
An update on human Th1 and Th2 cells 165
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 165
Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function. 161
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis 160
LIOFeron®TB/LTBI: A novel and reliable test for LTBI and tuberculosis 160
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease 159
Targeting of tumor cells by custom antigen transfer: a novel approach for immunotherapy of cancer 159
The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. 158
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 156
Cardiovascular oncology: a new discipline inside internal medicine? 155
Prevention of miscarriage in antiphospholipid syndrome 155
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 154
Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. 150
Moraxella catarrhalis-specific Th1 cells in BAL fluids of chronic obstructive pulmonary disease patients. 149
Behçet's syndrome pathophysiology and potential therapeutic targets 149
Differential Diagnosis 148
Case Report: Signal Transducer and Activator of Transcription 3 Gain-of-Function and Spectrin Deficiency: A Life-Threatening Case of Severe Hemolytic Anemia 148
Skin IL-17A and IFN-γ Production Correlate with Disease Severity in Patients with Psoriasis and Streptococcal Infection 146
Targeting IL-23 in human diseases. 146
Defining the Helicobacter pylori Disease-Specific Antigenic Repertoire 146
Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori Neutrophil Activating Protein 145
In vivo relevance of CD30 in atopic dermatitis. 144
Helicobacter pylori, T cells and cytokines: the "dangerous liaisons". 142
Decrease of serological markers of Th2 activity in a context of decreasing intestinal helminth prevalence: Chaco Region, Plurinational State of Bolivia 142
Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects 140
A CVID-associated variant in the ciliogenesis protein CCDC28B disrupts immune synapse assembly 140
Inflammation and host response. 139
Stimulation of TH1 response by Helicobacter pylori neutrophil activating protein decreases the protective role of IgE and eosinophils in experimental trichinellosis. 139
Prevalence of allergy and asthma in a rural community of children and adults in Bolivian Chaco 139
IFN-g-inducible protein (IP-10/CXCL)10 and pentraxin (PTX)3 plasma levels are tools for monitoring inflammation and disease activity in M. tuberculosis infection. 139
Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine. 137
Usefulness of 13C-Urea Breath Test in the diagnosis of gastric Helicobacter pylori infection. 137
Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma 136
Impaired TH2 response in patients with Vav1-deficient common variable immunodeficiency with T-cell defects. 135
Elevated IL-19 Serum Levels in Patients With Pernicious Anemia and Autoimmune Gastritis 134
Helicobacter pylori and gastric autoimmunity. 134
Preferential expression of CD30 by human CD4+ T-cells producing Th2-type cytokines. 133
New frontiers in cell-based immunotherapy of cancer. 133
Pulmonary hemorrhage: not only vasculitis. 133
Suppression of T-lymphocyte activation and chemotaxis by the adenylate cyclase toxin of Bordetella pertussis. 133
Novel immunotherapeutic strategies of gastric cancer treatment 132
Totale 20.697
Categoria #
all - tutte 86.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.188


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.371 0 0 0 0 0 0 191 257 218 387 100 218
2021/20221.452 43 153 108 68 58 48 48 96 63 60 255 452
2022/20233.741 376 630 163 271 298 644 433 399 319 21 120 67
2023/20241.233 47 150 251 66 71 251 39 161 18 89 50 40
2024/20259.302 332 1.003 621 1.381 2.623 1.134 115 630 482 299 342 340
2025/20265.998 1.144 1.485 822 782 968 405 392 0 0 0 0 0
Totale 33.551